Vantage logo

Viridian takes on Horizon

Early data in thyroid eye disease impress, but unanswered questions include the size of the market.

Vantage logo

Zantac burns big pharma

As Zantac litigation risk wipes $43bn off public company valuations are investors right to be worried?